Cargando…
T-cell Redirecting Therapies for the Treatment of B-cell Lymphomas: Recent Advances
SIMPLE SUMMARY: B-cell non-Hodgkin lymphomas (NHL) include many diseases with distincts pathogenic mechanisms, prognoses and management. Most patients benefit generally from efficient therapies allowing cure or prolonged remission. However, when they are refractory or relapse after standard therapy,...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8428367/ https://www.ncbi.nlm.nih.gov/pubmed/34503084 http://dx.doi.org/10.3390/cancers13174274 |